Recent Finacing
Recent Raise
Thrasos Therapeutics is a private, clinical-stage biotherapeutics company developing THR-184, a BMP/Smad-targeting peptide in Phase 2 trials to prevent acute kidney injury and pursue CKD programs.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
